Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 3, 2004

View Archived Issues

Gusperimus shows efficacy in SLE-associated glomerulonephritis

New atherosclerosis vaccine developed by GSK team

New vitamin D analogues and their use in bone diseases, cancer, etc.

Novel Src kinase inhibitors covered by AstraZeneca patent

New factor Xa inhibitors in early development at Boehringer Ingelheim

New CD80 antagonists and their use claimed by Avidex

New phenylsulfonamide-based gamma-secretase inhibitors and their use in AD

New factor XIa inhibitors identified by BMS researchers

New Chk1 kinase inhibitors under study at Abbott

Novel syncretic antiarthritic agents by CombinatoRx

Novel quinoxaline topoisomerase I inhibitor

Novel proteasome inhibitor shows efficacy against human prostate carcinoma in vitro

NovaDel Pharma licenses lingual ondansetron spray to Hana Biosciences

Oxford BioMedica and Arius Research extend cancer collaboration

Six months additional U.S. market exclusivity for Adderall XR

Takeda submits Actoplus Met NDA for type 2 diabetes

New oral solution of Levaquin approved

Protein Sciences cleared to begin phase II/III FluBlok study

Preclinical data on the antimicrobial activity of PPI-0903 reported at ICAAC

Aastrom signs diabetic limb ischemia trial agreement

Tipranavir/ritonavir shows antiviral efficacy in advanced HIV disease

Effective management of postoperative dental pain achieved with cimicoxib

Dosing commences in phase IIIb study of rhIGF-1 for primary IGF-1 deficiency

Approvable letter for Arcoxia

STTR grant for PET imaging efforts at Attenuon

Good gastrointestinal safety profile reported for etoricoxib in OA patients

Plexxikon and Wyeth team up to develop PPAR modulators

New Broad-Novartis Diabetes Initiative for type 2 diabetes

Eisai reacquires ravuconazole rights

Partial clinical hold lifted from Stanate

Priority review for Temodar sNDA

Update on the pharmacokinetics and antibacterial activity of doripenem

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...